Cholinergic regulation of thymocyte negative selection
- PMID: 40399609
- DOI: 10.1038/s41590-025-02152-4
Cholinergic regulation of thymocyte negative selection
Abstract
The immune and nervous systems use a common chemical language for communication, namely, the cholinergic signaling involving acetylcholine (ACh) and its receptors (AChRs). Whether and how this language also regulates the development of the immune system is poorly understood. Here, we show that mouse CD4+CD8+ double-positive thymocytes express high levels of α9 nicotinic AChR (nAChR) and that this receptor controls thymic negative selection. α9 nAChR-deficient mice show an altered T cell receptor (TCR) repertoire and reduced CD4+ and CD8+ T cells in a mixed bone marrow chimera setting. α9 nAChR-mediated signaling regulates TCR strength and thymocyte survival. Thymic tuft cells, B cells and some T cells express choline acetyltransferase and are potential ACh sources, with ACh derived from T cells having the most important role. Furthermore, α9 nAChR deficiency during thymocyte development contributes to the altered development of autoimmune diseases in mice. Our results thus reveal a mechanism controlling immune cell development that involves cholinergic signaling.
© 2025. The Author(s), under exclusive licence to Springer Nature America, Inc.
Conflict of interest statement
Competing interests: T.W.M. holds equity in Treadwell Therapeutics Inc. and is a consultant for AstraZeneca Inc. H.Q. is a cofounder of Emergent Biomed Solutions, Ltd. P.S.O. is a Scientific Advisory Board member for Providence Therapeutics, Tikva Allocell and Rondo Therapeutics, Inc. P.S.O. also holds a sponsored research agreement with Providence Therapeutics. The other authors declare no competing interests.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials